NCT06338605View on ClinicalTrials.gov

Evaluating the Incidence of Pseudo-Acute Kidney Injuries in Patients With Metastatic Breast Cancer on CDK4/6 Inhibitors Trough Cystatin C Analysis

Active, not recruitingOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

December 12, 2023

Primary Completion Date

April 1, 2024

Study Completion Date

June 1, 2024

Conditions
Advanced Breast Cancer
Interventions
OTHER

no intervention, observational study of AKI under CDK4/6 inhibitor treatment

no intervention

Trial Locations (1)

Unknown

Erasmus Medical Center, Rotterdam

Sponsors
All Listed Sponsors
lead

Erasmus Medical Center

OTHER

NCT06338605 - Evaluating the Incidence of Pseudo-Acute Kidney Injuries in Patients With Metastatic Breast Cancer on CDK4/6 Inhibitors Trough Cystatin C Analysis | Biotech Hunter | Biotech Hunter